Irina Mayberry
Nurse Practitioner · Lynn Haven, FLNPI 1083495980
Payments from drug & device makers
Across 110 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$381
- Bayer$276
- Regeneron Healthcare Solutions, Inc.$171
- Lilly USA, LLC$124
- AstraZeneca$120
- Amgen$116
- plus $892 from 19 others
What the payments were for
- Food & beverage$2,079100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $381 |
| Bayer | 9 | $276 |
| Regeneron Healthcare Solutions, Inc. | 6 | $171 |
| Lilly USA, LLC | 6 | $124 |
| AstraZeneca(2 entities) | 6 | $120 |
| Amgen | 7 | $116 |
| Tandem Diabetes Care, Inc. | 3 | $92 |
| Medtronic | 3 | $89 |
| Xeris Pharmaceuticals, Inc. | 4 | $85 |
| Amneal Pharmaceuticals LLC | 5 | $85 |
| Novartis | 5 | $76 |
| AbbVie | 4 | $60 |
| Sequel Med Tech, LLC | 2 | $57 |
| Ascensia Diabetes Care US Inc. | 3 | $48 |
| Corcept Therapeutics | 2 | $41 |
| Boehringer Ingelheim | 2 | $37 |
| Insulet Corporation | 1 | $34 |
| Chiesi USA, Inc. | 1 | $32 |
| BETA Bionics, Inc. | 3 | $28 |
| GSK | 1 | $26 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Abbott | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$125
How this compares
$2,079 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 314 | $385,943 |
| OzempicSemaglutide | 293 | $341,531 |
| JardianceEmpagliflozin | 103 | $144,038 |
| Tresiba Flextouch U-200Insulin Degludec | 55 | $105,674 |
| TrulicityDulaglutide | 65 | $99,041 |
| FarxigaDapagliflozin Propanediol | 48 | $66,788 |
| JanuviaSitagliptin Phosphate | 47 | $47,014 |
| Tresiba Flextouch U-100Insulin Degludec | 32 | $30,266 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $27,968 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $24,847 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 23 | $22,734 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 20 | $20,511 |
| Humalog Kwikpen U-100Insulin Lispro | 54 | $18,517 |
| Novolog FlexpenInsulin Aspart | 51 | $16,135 |
| HumalogInsulin Lispro | 33 | $16,119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Humulin 70-30, Insulin Lispro | $124 | $505,499439 claims |
| Novo NordiskOzempic, Novolog | $381 | $348,835308 claims |
| Boehringer IngelheimJardiance | $37 | $144,038103 claims |
| AstraZenecaFarxiga | $120 | $66,78848 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $85 | $4,191380 claims |
| AbbVieSynthroid | $60 | $3,57140 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Lynn Haven
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.